Scarica l'app Stockscreener
42.69
7.22%
-3.32
Precedente Chiudi:
$46.01
Aprire:
$46.25
Volume 24 ore:
5.69M
Relative Volume:
0.92
Capitalizzazione di mercato:
$7.69B
Reddito:
$1.36B
Utile/perdita netta:
$-302.91M
Rapporto P/E:
-24.85
EPS:
-1.7182
Flusso di cassa netto:
$-219.93M
1 W Prestazione:
-18.64%
1M Prestazione:
-17.81%
6M Prestazione:
-34.64%
1 anno Prestazione:
-32.60%
Intervallo 1D:
$42.66
$46.45
Intervallo di 1 settimana:
$42.66
$50.01
Portata 52W:
$41.73
$104.32
Tempus Ai Inc Stock (TEM) Company Profile
Nome
Tempus Ai Inc
Settore
Industria
Telefono
800-976-5448
Indirizzo
600 WEST CHICAGO AVENUE, CHICAGO
Compare TEM vs VEEV, BTSG, HQY, TXG
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TEM
Tempus Ai Inc
|
42.69 | 7.69B | 1.36B | -302.91M | -219.93M | -1.7182 |
VEEV
Veeva Systems Inc
|
186.24 | 30.25B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
72.91 | 14.31B | 13.65B | 169.86M | 412.12M | 1.0758 |
HQY
Healthequity Inc
|
94.64 | 7.91B | 1.34B | 230.70M | 440.96M | 2.6695 |
TXG
10 X Genomics Inc
|
46.27 | 5.87B | 638.78M | -22.66M | 122.18M | -0.1744 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-13 | Iniziato | Jefferies | Underperform |
| 2026-04-13 | Aggiornamento | TD Cowen | Hold → Buy |
| 2026-02-19 | Iniziato | Mizuho | Outperform |
| 2026-02-17 | Iniziato | Robert W. Baird | Outperform |
| 2025-12-02 | Ripresa | Morgan Stanley | Overweight |
| 2025-10-21 | Downgrade | TD Cowen | Buy → Hold |
| 2025-10-20 | Iniziato | Canaccord Genuity | Buy |
| 2025-09-02 | Iniziato | H.C. Wainwright | Buy |
| 2025-04-21 | Iniziato | BTIG Research | Buy |
| 2025-02-25 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-02-12 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2025-02-05 | Ripresa | TD Cowen | Buy |
| 2024-12-13 | Iniziato | Wolfe Research | Outperform |
| 2024-12-09 | Iniziato | Guggenheim | Buy |
| 2024-11-11 | Downgrade | Stifel | Buy → Hold |
| 2024-10-02 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-08-12 | Iniziato | Piper Sandler | Neutral |
| 2024-07-09 | Iniziato | BofA Securities | Buy |
| 2024-07-09 | Iniziato | JP Morgan | Overweight |
| 2024-07-09 | Iniziato | Longbow | Buy |
| 2024-07-09 | Iniziato | Loop Capital | Buy |
| 2024-07-09 | Iniziato | Morgan Stanley | Overweight |
| 2024-07-09 | Iniziato | Needham | Buy |
| 2024-07-09 | Iniziato | Stifel | Buy |
| 2024-07-09 | Iniziato | TD Cowen | Buy |
| 2024-07-09 | Iniziato | William Blair | Outperform |
Mostra tutto
Tempus Ai Inc Borsa (TEM) Ultime notizie
Alan Tan: Highlighting Ultrasensitive MRD Detection with Tempus AI at KCRS26 - Oncodaily
136,636 Shares in Tempus AI, Inc. $TEM Acquired by Aristotle Atlantic Partners LLC - MarketBeat
Analysts Offer Insights on Healthcare Companies: Tempus AI, Inc. Class A (TEM), Brainsway (BWAY) and Argenx Se (ARGX) - The Globe and Mail
Tempus AI Inc (TEM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Tempus AI Inc (TEM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Tempus AI Inc|Price:42.690|Chg%:-3.320 - TradingKey
Tempus AI (NASDAQ:TEM) Upgraded to Hold at Wall Street Zen - MarketBeat
Tempus AI stock: H.C. Wainwright reiterates Buy on MRD expansion - Investing.com UK
Tempus AI buys Personalis for $1.5B; UCSF Health, Kleiner Perkins and Doerr Capital launch health AI accelerator; Candid Health raises $120M - VatorNews
Tempus AI Stock Before Q2 Earnings Release: To Buy, Hold or Sell? - Yahoo Finance
Tempus to acquire Personalis in $1.5 billion deal to expand MRD capabilities - DOTmed
Tempus AI stock: H.C. Wainwright reiterates Buy on MRD expansion By Investing.com - Investing.com Canada
GC Wealth Management RIA LLC Cuts Position in Tempus AI, Inc. $TEM - MarketBeat
Cathie Wood buys $8.7 million of beaten-down AI stock - thestreet.com
Artificial Intelligence Stocks To Follow NowJuly 23rd - MarketBeat
Tempus AI (TEM) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release - Yahoo! Finance Canada
Tempus AI (TEM) Expected to Announce Earnings on Thursday - MarketBeat
Tempus AI (TEM) Unveils National Rollout of Pharmacogenomics Tes - GuruFocus
Tempus AI Expands Cancer Platform With Launch of ArteraAI Prostate Test For Metastatic Patients - Stocktwits
Tempus makes $1.5B bet to corner cancer-test market - thestreet.com
Tempus AI Makes Billion-Dollar Bet on the Future of Cancer Monitoring - Sahm
What's behind Tempus AI's latest 3.5% stock pullback? - Traders Union
Best Artificial Intelligence Stocks To Follow TodayJuly 22nd - MarketBeat
Why is Tempus AI stock sliding today? By Investing.com - Investing.com Canada
Tempus AI launches pharmacogenomics testing nationwide By Investing.com - Investing.com Nigeria
Tempus AI launches pharmacogenomics testing nationwide - Investing.com
Tempus Launches Test for Therapies With Nearly 30% Severe Toxicities - Stock Titan
Tempus AI to Acquire Cancer Diagnostics Firm Personalis for approximately $1.5 Billion, Targeting MRD Market Leadership - finance.biggo.com
Tempus AI (TEM) On Its Personalis Deal And Whether The Bull Case Is Priced In - Yahoo Finance
Cathie Wood’s Tempus AI Bet Is Bleeding — And the Chart Looks Worse Than Wall Street Thinks - Sahm
Tempus to acquire Personalis, Inc. (PSNL) in cash and stock merger - Stock Titan
Tempus AI: Buy Rating Reaffirmed as Personalis Deal Strengthens MRD Position; $75 Price Target Maintained - TipRanks
Why Is Tempus AI Stock Volatile Tuesday?Personalis (NASDAQ:PSNL), Tempus AI (NASDAQ:TEM) - Benzinga
TEM, PSNL stocks are falling — why Morgan Stanley still likes Tempus AI’s Personalis deal - MSN
Tempus AI buys Personalis for $1.5 billion - grafa.com
Artificial Intelligence Stocks To Add to Your WatchlistJuly 21st - MarketBeat
Tempus AI Buys Personalis for $1.5B to Boost Cancer Monitoring - Medical Device and Diagnostic industry
Tempus AI to Acquire Personalis for $1.5 Billion to Expand Precision Oncology Platform - HLTH
Tempus AI Stock Short Interest Falls to 33.94% - Quiver Quantitative
Tempus AI is acquiring cancer-monitoring firm Personalis in a $1.5 billion stock deal - qz.com
Tempus AI Acquires Personalis: Why Both Stocks Are A Buy Now (NASDAQ:TEM) - Seeking Alpha
Tempus AI acquires cancer-monitoring firm Personalis for $1.5 billion - Yahoo Finance
Tempus AI acquires Personalis in $1.5bn precision oncology-focused deal - Yahoo Finance
Tempus AI snaps up genomics partner Personalis for $1.5 billion - The Pharma Letter
Tempus AI (TEM) to Acquire Personalis in Strategic Move - GuruFocus
Tempus AI (TEM) Is Buying Personalis For $1.5 Billion To Deepen Cancer Monitoring - Yahoo Finance
Tempus AI (TEM) Stock May Be A Bargain Despite Its 22% Slump - Yahoo Finance
Tempus AI, Inc. $TEM Stake Boosted by Amova Asset Management Americas Inc. - MarketBeat
Personalis, Inc. (PSNL) Tempus AI, Inc.M&A CallSlideshow (NASDAQ:PSNL) 2026-07-20 - Seeking Alpha
Tempus AI Stock Near 1-Year Low: Cathie Wood’s ARK Buys More While Offloading Nvidia, Meta, Other Tech Plays - Stocktwits
Jefferies reiterates Tempus AI stock rating on acquisition concerns By Investing.com - Investing.com South Africa
Tempus Ai Inc Azioni (TEM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.32%
3.72%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):